Redx Pharma Plc (LON:REDX – Get Rating)’s share price crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 56.59 ($0.67) and traded as low as GBX 56.10 ($0.66). Redx Pharma shares last traded at GBX 56.10 ($0.66), with a volume of 3,552 shares traded.
Redx Pharma Price Performance
The company has a current ratio of 2.11, a quick ratio of 1.93 and a debt-to-equity ratio of 331.56. The stock has a market cap of £194.25 million and a price-to-earnings ratio of -6.90. The stock has a 50-day moving average price of GBX 56.59 and a two-hundred day moving average price of GBX 60.28.
About Redx Pharma
Redx Pharma Plc engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom. It discovers and develops small molecule drugs for treating anti-cancer and fibrosis targets in the areas of unmet medical needs. The company also develops RXC004, a porcupine inhibitor that is in Phase II clinical trial for targeted therapy of Wnt-ligand driven cancer; and RXC007, an oral selective rho associated coiled-coil containing protein kinase 2 (ROCK2) inhibitor for the treatment of fibrotic diseases.
- Three CBD Stocks to Dominate a Budding Industry
- Is the 60/40 Portfolio Mix Still in Vogue?
- Microsoft Shares: Is it Time to Back Up the Truck?
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Institutional Support for Analog Devices Remains High
Receive News & Ratings for Redx Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Redx Pharma and related companies with MarketBeat.com's FREE daily email newsletter.